Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FENNEC PHARMACEUTICALS INC.

(FENC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 126129192239--
Entreprise Value (EV)1 126129192239239239
P/E ratio -12,3x-10,1x-9,80x-13,9x-71,8x9,01x
Yield ------
Capitalization / Revenue --1 131x11,4x11,9x4,05x
EV / Revenue --1 131x11,4x11,9x4,05x
EV / EBITDA ------
Price to Book ------
Nbr of stocks (in thousands) 19 72919 89625 81026 007--
Reference price (USD) 6,386,497,459,199,199,19
Announcement Date 03/13/201902/14/202003/30/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 --0,1721,020,159,1
EBITDA ------
Operating profit (EBIT)1 -10,4-13,0-17,9-17,6-3,8026,6
Operating Margin ---10 521%-83,5%-18,9%45,0%
Pre-Tax Profit (EBT)1 -9,89-12,8-18,1-17,4-3,5927,2
Net income1 -9,89-12,8-18,1-17,4-3,6426,8
Net margin ---10 652%-82,9%-18,1%45,3%
EPS2 -0,52-0,64-0,76-0,66-0,131,02
Dividend per Share ------
Announcement Date 03/13/201902/14/202003/30/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 0,17---21,01,92
EBITDA ------
Operating profit (EBIT)1 -3,35-4,92-3,92-4,43-4,19-4,28
Operating Margin -1 968%----19,9%-223%
Pre-Tax Profit (EBT)1 -3,24-4,73-4,00-4,42-4,18-4,26
Net income1 -3,24-4,73-4,00-4,42-4,18-4,26
Net margin -1 905%----19,9%-222%
EPS2 -0,13-0,18-0,15-0,17-0,17-0,11
Dividend per Share ------
Announcement Date 03/30/202105/13/202108/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 ----15,2-8,7529,6
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex ------
Capex / Sales ------
Announcement Date 03/13/201902/14/202003/30/2021---
1 USD in Million
Key data
Capitalization (USD) 239 002 979
Net sales (USD) 170 000
Number of employees 9
Sales / Employee (USD) 18 889
Free-Float 83,1%
Free-Float capitalization (USD) 198 511 214
Avg. Exchange 20 sessions (USD) 428 992
Average Daily Capital Traded 0,18%
EPS & Dividend